GABRA5 | Gamma-aminobutyric acid (GABA) A receptor, alpha 5 | FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
GAP43 | Growth associated protein 43 | Plasma proteins Predicted intracellular proteins Transporters
| | | | | Tissue enriched |
HAPLN2 | Hyaluronan and proteoglycan link protein 2 | Predicted secreted proteins
| | | | | Tissue enriched |
FXYD7 | FXYD domain containing ion transport regulator 7 | Predicted membrane proteins
| | | | | Tissue enriched |
GPM6B | Glycoprotein M6B | Predicted membrane proteins
| | | | | Tissue enriched |
OPCML | Opioid binding protein/cell adhesion molecule-like | Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
SYN2 | Synapsin II | Predicted intracellular proteins
| | | | | Tissue enriched |
SLC32A1 | Solute carrier family 32 (GABA vesicular transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CORT | Cortistatin | Predicted secreted proteins
| | | | | Tissue enriched |
GPM6A | Glycoprotein M6A | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
KCNV1 | Potassium channel, subfamily V, member 1 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
TNR | Tenascin R | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
KCNF1 | Potassium voltage-gated channel, subfamily F, member 1 | Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enriched |
MOBP | Myelin-associated oligodendrocyte basic protein | Predicted intracellular proteins
| | | | | Tissue enriched |
ATP6V1G2 | ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 | Predicted intracellular proteins
| | | | | Tissue enriched |
CASKIN1 | CASK interacting protein 1 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
GRIN2B | Glutamate receptor, ionotropic, N-methyl D-aspartate 2B | Disease related genes FDA approved drug targets Predicted membrane proteins RAS pathway related proteins
| | | | | Tissue enriched |
SYN1 | Synapsin I | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
MEPE | Matrix extracellular phosphoglycoprotein | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
NPTX1 | Neuronal pentraxin I | Predicted secreted proteins
| | | | | Tissue enriched |
SNAP25 | Synaptosomal-associated protein, 25kDa | FDA approved drug targets Predicted intracellular proteins Transporters
| | | | | Tissue enriched |
CACNG3 | Calcium channel, voltage-dependent, gamma subunit 3 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
HS3ST2 | Heparan sulfate (glucosamine) 3-O-sulfotransferase 2 | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
KIF5A | Kinesin family member 5A | Disease related genes Predicted intracellular proteins
| | | | | Tissue enriched |
SEPT3 | Septin 3 | Predicted intracellular proteins
| | | | | Tissue enriched |
CNTNAP4 | Contactin associated protein-like 4 | Predicted membrane proteins
| | | | | Tissue enriched |
PACSIN1 | Protein kinase C and casein kinase substrate in neurons 1 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
NRXN1 | Neurexin 1 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
NTSR2 | Neurotensin receptor 2 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
SULT4A1 | Sulfotransferase family 4A, member 1 | Predicted intracellular proteins
| | | | | Tissue enriched |
TRIM67 | Tripartite motif containing 67 | Cytoskeleton related proteins Predicted intracellular proteins
| | | | | Tissue enriched |
KCNA1 | Potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia) | Disease related genes FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
STMN4 | Stathmin-like 4 | Predicted intracellular proteins
| | | | | Tissue enriched |
BCAN | Brevican | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
C11orf87 | Chromosome 11 open reading frame 87 | Predicted membrane proteins
| | | | | Tissue enriched |
JPH3 | Junctophilin 3 | Disease related genes Predicted membrane proteins
| | | | | Tissue enriched |
SCN2A | Sodium channel, voltage-gated, type II, alpha subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enriched |
SHANK1 | SH3 and multiple ankyrin repeat domains 1 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
SLC4A10 | Solute carrier family 4, sodium bicarbonate transporter, member 10 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SV2B | Synaptic vesicle glycoprotein 2B | Predicted membrane proteins
| | | | | Tissue enriched |
TMEM151A | Transmembrane protein 151A | Predicted membrane proteins
| | | | | Tissue enriched |
AK5 | Adenylate kinase 5 | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
GPR158 | G protein-coupled receptor 158 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
GPR26 | G protein-coupled receptor 26 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
LRRTM4 | Leucine rich repeat transmembrane neuronal 4 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
OLFM1 | Olfactomedin 1 | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
RPH3A | Rabphilin 3A | Predicted intracellular proteins
| | | | | Tissue enriched |
STX1B | Syntaxin 1B | Cytoskeleton related proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
APC2 | Adenomatosis polyposis coli 2 | Predicted intracellular proteins
| | | | | Tissue enriched |
CTNND2 | Catenin (cadherin-associated protein), delta 2 | Predicted intracellular proteins
| | | | | Tissue enriched |